Companies House · 06569105

ITH PHARMA LIMITED

UK registered company, private limited company, incorporated 17 Apr 2008.

Active

50
Public contracts: 0
Spend payments: —
Total spend

ITH PHARMA LIMITED is a UK company registered at Companies House under number 06569105. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number: 06569105
Status: Active
Company type: Private Limited Company
Incorporated: 17 Apr 2008
Country of origin: United Kingdom
Registered office: 4TH FLOOR, LONDON, EC2V 7AB, UNITED KINGDOM
Nature of business (SIC): 32990 - Other manufacturing n.e.c.
Accounts category: FULL

View source on data.gov.uk

Public sector contracts

Contract awards linked to ITH PHARMA LIMITED.

Procurement	Buyer	Awarded	Value
Framework Agreement for Parenteral Nutrition Products 2022	Guy's and St Thomas' NHS Foundation Trust	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
Parenteral Nutrition for Adults, Paediatrics, and Neonates	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	—	—
Parenteral Nutrition Formulation Bags for Neo Nates	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Compounded Aseptic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	—	—
NP38619 Compounded Aseptic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Compounded Aseptic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	—	—
Supply of dose banded compounded chemotherapy	Berkshire Healthcare NHS Foundation Trust	—	—
Supply of Parenteral Nutrition Adult Starter Bags and Neonatal Bags	Royal Devon and Exeter NHS Foundation Trust	—	—
Supply of Parenteral Nutrition Adult Starter Bags and Neonatal Bags	Royal Devon and Exeter NHS Foundation Trust	—	—
Framework Agreement for Parenteral Nutrition Products 2022	Guy's and St Thomas' NHS Foundation Trust	—	—
Framework Agreement for Parenteral Nutrition Products 2022	Guy's and St Thomas' NHS Foundation Trust	—	—
D105 - Framework for the Supply of Ready to Administer Products	University Hospitals of Derby and Burton NHS Foundation Trust	—	—
D105 - Framework for the Supply of Ready to Administer Products	University Hospitals of Derby and Burton NHS Foundation Trust	—	—
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)	NHS England	—	—
YHPPC - Unlicensed Parenteral Nutrition (PN)	Leeds Teaching Hospitals NHS Trust	—	—
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Supply of Parenteral Nutrition Products	Berkshire Healthcare NHS Foundation Trust	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England	The NHS Commissioning Board (operating under the name of NHS England)	—	—
Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services	University Hospitals of Derby and Burton NHS Foundation Trust	—	£9m
Adult and Paediatric Nutrition	University Hospitals of Derby and Burton NHS Foundation Trust	—	£1.5m
D105 - Framework for the Supply of Ready to Administer Products	University Hospitals of Derby and Burton NHS Foundation Trust	18 Aug 2025	£6.4m
YHPPC - Unlicensed Parenteral Nutrition (PN)	Leeds Teaching Hospitals NHS Trust	22 Mar 2024	£20m
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)	NHS England	11 Mar 2024	£608m

Supplier identities

How this company appears as a supplier across the data.

FAQs about ITH PHARMA LIMITED

Is ITH PHARMA LIMITED an active company?

ITH PHARMA LIMITED (company number 06569105) is recorded as "Active", incorporated on 17 Apr 2008.

What does ITH PHARMA LIMITED do?

Its Companies House nature-of-business (SIC) is: 32990 - Other manufacturing n.e.c..

Has ITH PHARMA LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is ITH PHARMA LIMITED based?

Its registered office is 4TH FLOOR, LONDON, EC2V 7AB, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable